Skip Navigation

JNCI Journal of the National Cancer Institute 1991 83(4):274-280; doi:10.1093/jnci/83.4.274
© 1991 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Coghlin, J.
Right arrow Articles by Tannenbaum, StevenR.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coghlin, J.
Right arrow Articles by Tannenbaum, StevenR.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 83, No. 4, 274-280, February 20, 1991
© 1991 Oxford University Press

4-Aminobipheny1 Hemoglobin Adducts in Fetuses Exposed to the Tobacco Smoke Carcinogen In Utero

Jacalyn Coghlin*, Peter H. Gann, S. Katharine Hammond, Paul L Skipper, Koli Taghizadeh, Maureen Paul, StevenR. Tannenbaum

1Division of Preventive Medicine, Department of Family and Community Medicine, University of Massachusetts Medical Worcester, Mass.
2Division of Environmental Health Sciences, Department of Family and Community Medicine, University of Massachusetts Medical Worcester, Mass.
3Division of Occupational Health, Department of Family and Community Medicine, University of Massachusetts Medical Worcester, Mass.
4Department of Chemistry, Division of Tozicology, Massachusetts Institute of Technology Cambridge, Mass

*Correspondence to: Jacalyn Coglin, MD, Department of Family and Community Medicine, University of Massachusetts Medical Center, Rm. S4–326, 55 Lake AveN, Worcester, MA01655.

Maternal-fetal exchange of a potent tobacco-related human carcinogen, 4-aminobiphenyl, was studied in smoking(n=14) and nonsmoking (n=38) pregnant women. N-Hydroxy-4-aminobiphenyl, the active metabolite of 4-aminobiphenyl, forms chemical addition products (adducts) with hemoglobin. Levels of 4-aminobiphenyl hemoglobin adducts were measured in maternal-fetal paired blood samples obtained from smoking and nonsmoking women during labor and delivery. Carcinogen-hemoglobin adducts were detected in all maternal and fetal blood samples.Levels of such adducts were significantly higher (P<.001) in maternal and fetal blood samples from smokers: the mean 4-aminobiphenyl hemoglobin adduct level was 92+54 pg/g of hemoglobin in blood samples from fetuses of smokers, and 17+13 pg/g of hemoglobin in blood samples from fetuses of nonsmokers; the mean maternal 4-aminobiephenyl hemoglobin adduct level was 183 108 pg/g of hemoglobin in smokers, and 22 pg/g of hemoglobin in nonsmokers. Fetal Carcinogen-adduct levels were consistently lower than maternal levels: the mean maternal to fetal ratio was 2.4 1.1 in smokers and 1.9 98in nonsmokers. Fetal 4-aminobiphenyl hemoglobin adduct levels were strongly associated(correlation coefficient(r2)=.51, P=.002) with maternal 4-aminobiphenyl hemoglobin adduct levels when paired samples from smoking mothers were analyzed. A measure of third trimester to bacco smoke exposure based on number of cigarettes smoked per day, amount of each cigarette smoked, and depth of inhalation was associated (r2=.59, P=.029) with maternal 4-aminobiphenyl levels but not with fetal 4-aminobiphenyl levels. This study demonstrates that a potent tobacco-related carcinogen, 4-aminobiphenyl, or its active metabolite, N-hydroxy-4-aminobiphenyl, crosses the human placenta and binds to fetal hemoglobin in concentrations that are significantly higher in smokers than in nonsmokers. [J Natl Cancer Inst 83: 274–280, 1991]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
PediatricsHome page
D. Best, Committee on Environmental Health, Committee on Native American Child Health, and Committee on Adolescence
Secondhand and Prenatal Tobacco Smoke Exposure
Pediatrics, November 1, 2009; 124(5): e1017 - e1044.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. L. Skipper, S. R. Tannenbaum, R. K. Ross, and M. C. Yu
Nonsmoking-related Arylamine Exposure and Bladder Cancer Risk
Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 503 - 507.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. H. Phillips
Smoking-related DNA and protein adducts in human tissues
Carcinogenesis, December 1, 2002; 23(12): 1979 - 2004.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
D. W. Hein, C. A. McQueen, D. M. Grant, G. H. Goodfellow, F. F. Kadlubar, and W. W. Weber
Pharmacogenetics of the Arylamine N-Acetyltransferases: A Symposium in Honor of Wendell W. Weber
Drug Metab. Dispos., April 13, 2001; 28(12): 1425 - 1432.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. Tang, D. Warburton, S. R. Tannenbaum, P. Skipper, R. M. Santella, G. S. Cereijido, F. G. Crawford, and F. P. Perera
Molecular and Genetic Damage from Environmental Tobacco Smoke in Young Children
Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 427 - 431.
[Abstract] [Full Text]


Home page
Hum Exp ToxicolHome page
A. J Sasco and H. Vainio
From in utero and childhood exposure to parental smoking to childhood cancer: a possible link and the need for action
Human and Experimental Toxicology, April 1, 1999; 18(4): 192 - 201.
[Abstract] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. M. Lackmann, U. Salzberger, U. Tollner, M. Chen, S. G. Carmella, and S. S. Hecht
Metabolites of a Tobacco-Specific Carcinogen in Urine From Newborns
J Natl Cancer Inst, March 3, 1999; 91(5): 459 - 465.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. Datta, P. M. Sherblom, and A. P. Kulkarni
Co-oxidative Metabolism of 4-Aminobiphenyl by Lipoxygenase from Soybean and Human Term Placenta
Drug Metab. Dispos., February 1, 1997; 25(2): 196 - 105.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.